rs776570317

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_001145809.2(MYH14):​c.3571G>T​(p.Ala1191Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000618 in 1,457,270 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000062 ( 0 hom. )

Consequence

MYH14
NM_001145809.2 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.27

Publications

1 publications found
Variant links:
Genes affected
MYH14 (HGNC:23212): (myosin heavy chain 14) This gene encodes a member of the myosin superfamily. The protein represents a conventional non-muscle myosin; it should not be confused with the unconventional myosin-14 (MYO14). Myosins are actin-dependent motor proteins with diverse functions including regulation of cytokinesis, cell motility, and cell polarity. Mutations in this gene result in one form of autosomal dominant hearing impairment. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]
MYH14 Gene-Disease associations (from GenCC):
  • autosomal dominant nonsyndromic hearing loss 4A
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • nonsyndromic genetic hearing loss
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.14185762).
BS2
High AC in GnomAdExome4 at 9 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYH14NM_001145809.2 linkc.3571G>T p.Ala1191Ser missense_variant Exon 28 of 43 ENST00000642316.2 NP_001139281.1
MYH14NM_001077186.2 linkc.3472G>T p.Ala1158Ser missense_variant Exon 27 of 42 NP_001070654.1
MYH14NM_024729.4 linkc.3448G>T p.Ala1150Ser missense_variant Exon 26 of 41 NP_079005.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYH14ENST00000642316.2 linkc.3571G>T p.Ala1191Ser missense_variant Exon 28 of 43 NM_001145809.2 ENSP00000493594.1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
0.00000618
AC:
9
AN:
1457270
Hom.:
0
Cov.:
32
AF XY:
0.00000414
AC XY:
3
AN XY:
724562
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33402
American (AMR)
AF:
0.00
AC:
0
AN:
44222
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25992
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39556
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85282
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52682
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5482
European-Non Finnish (NFE)
AF:
0.00000810
AC:
9
AN:
1110496
Other (OTH)
AF:
0.00
AC:
0
AN:
60156
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.442
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33
ExAC
AF:
0.00000826
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Apr 21, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant classified as Uncertain Significance - Favor Benign. The p.Ala1191Ser va riant in MYH14 has not been previously reported in individuals with hearing loss , but has been identified in 1/44386 of European chromosomes by the Exome Aggreg ation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs776570317). Alth ough this variant has been seen in the general population, its frequency is not high enough to rule out a pathogenic role. Alanine (Ala) at position 1191 is not conserved in mammals or evolutionarily distant species and 9 species (Opossum, white-throated sparrow, medium ground finch, zebra finch, tibetan ground jay, tu rkey, X tropicalis, tetraodon and lamprey) carry a serine (Ser) at this position , raising the possibility that this change may be tolerated. Additional computat ional prediction tools suggest that the p.Ala1191Ser variant may impact the prot ein, though this information is not predictive enough to determine pathogenicity . In summary, while the clinical significance of the p.Ala1191Ser variant is unc ertain, its presence in various species suggests that it is more likely to be be nign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.080
BayesDel_addAF
Benign
-0.015
T
BayesDel_noAF
Benign
-0.26
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Benign
0.27
.;.;T;.;.;T;T
Eigen
Benign
-0.41
Eigen_PC
Benign
-0.37
FATHMM_MKL
Benign
0.28
N
LIST_S2
Benign
0.82
.;T;T;.;T;.;T
M_CAP
Benign
0.042
D
MetaRNN
Benign
0.14
T;T;T;T;T;T;T
MetaSVM
Benign
-0.54
T
MutationAssessor
Benign
1.4
.;.;L;.;.;L;.
PhyloP100
1.3
PrimateAI
Uncertain
0.48
T
PROVEAN
Benign
-1.1
.;N;.;.;.;.;.
REVEL
Benign
0.23
Sift
Benign
0.27
.;T;.;.;.;.;.
Sift4G
Benign
0.39
T;T;T;.;T;T;T
Polyphen
0.56
P;P;B;P;P;B;.
Vest4
0.17
MutPred
0.57
.;.;Gain of phosphorylation at A1150 (P = 0.0019);.;.;Gain of phosphorylation at A1150 (P = 0.0019);.;
MVP
0.81
MPC
0.21
ClinPred
0.23
T
GERP RS
3.5
Varity_R
0.066
gMVP
0.26
Mutation Taster
=88/12
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs776570317; hg19: chr19-50779351; API